Close
Nordic 9Nordic 9

Søren Holst (investor - Angel Investor)

Denmark
See something wrong or missing? Let us know
Offices:Copenhagen

Søren Holst used to work for Oticon and now works for Lars Kolind at Kolind A/S, while using Mahalo Consulting for making private investments.

Average round investment:2.14M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Italy Neuranix
Mostly invests in: Italy Italy (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Søren Holst

Name Criteria
Italy Biosline Holding
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Lorenzo Caporaletti
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Peter Zoth
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Lars Kolind
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Italy Pi Campus
72%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France Oskare Capital
71%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Advent France Biotechnology
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain CG Health Ventures
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Colibri Ventures
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Gavia Food Holding
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top